• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

U.S. Biomedical Advanced Research and Development Authority (BARDA)

MedTech 100 roundup: Ringing in the New Year with another high

January 4, 2021 By Sean Whooley

For the third time in the past four weeks, stocks within the medtech industry climbed to never-before-seen heights as 2021 reared its head. Previous highs have largely been a result of the FDA granting Moderna emergency use authorization for its vaccine candidate and its subsequent rollout to the U.S., joining the one made by Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX), […]

Filed Under: Business/Financial News, Featured, Funding Roundup, MassDevice Earnings Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Boston Scientific, Corinth MedTech, coronavirus, COVID-19, COVID-19 vaccine, Defense Production Act, DiaSorin, MedTech 100 Index, Medtronic, Olympus, Omnia Medical, Teleflex, U.S. Biomedical Advanced Research and Development Authority (BARDA), Veran Medical Technologies, Z-Medica

Chembio lands $12.7M from BARDA for point-of-care test

December 2, 2020 By Sean Whooley

Chembio Diagnostics (NSDQ:CEMI) announced that it received a $12.7 million contract from BARDA for its rapid COVID-19 test. Hauppauge, N.Y.-based Chembio said in a news release that the contract will support the development of and pursuit of FDA emergency use authorization (EUA) for its rapid, multi-plex DPP respiratory antigen panel point-of-care testing system ahead of […]

Filed Under: Business/Financial News, Contract Manufacturing, Diagnostics, Funding Roundup, Genomics/Molecular Diagnostics Tagged With: Chembio Diagnostics, coronavirus, COVID-19, U.S. Biomedical Advanced Research and Development Authority (BARDA)

NIH announces more than $98M in contracts for new COVID-19 testing tech

October 7, 2020 By Chris Newmarker

The National Institutes of Health today announced six new contracts worth $98.35 million for COVID-19 testing approaches to improve sample collection, processing and results. NIH awarded the contracts in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) as part of the Rapid Acceleration of Diagnostics (RADx) initiative. They cover innovations including integration with […]

Filed Under: Business/Financial News, Diagnostics, Digital Health, Featured, Funding Roundup Tagged With: coronavirus, COVID-19, Ellume, Flambeau Diagnostics, Luminostics, NIH, Quanterix Corp., U.S. Biomedical Advanced Research and Development Authority (BARDA), Ubiquitome, Visby Medical

HHS gives Vaxxas $22M to support vaccine patch tech

October 5, 2020 By Chris Newmarker

Vaxxas announced today that it has received a $22 million award from the Biomedical Advanced Research and Development Authority (BARDA) at U.S. HHS to support a clinical study involving the company’s vaccine-delivery patch. The money will mostly pay for a Phase 1 clinical study in which Vaxxas’ high-density micro-array patch (HD-MAP) delivering pandemic influenza vaccine to […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), U.S. Biomedical Advanced Research and Development Authority (BARDA), Vaxxas

Feds target Medtronic in ventilator antitrust investigation

September 30, 2020 By Nancy Crotti

Medtronic (NYSE:MDT) is under investigation by the federal government for allegedly limiting competition in the ventilator business, the company acknowledged late yesterday. The civil antitrust probe grew out of complaints about device shortages during the coronavirus pandemic, according to a report by the Wall Street Journal. The Journal cited “people familiar with the matter” as saying […]

Filed Under: Business/Financial News, Featured, Legal News, Respiratory, Wall Street Beat Tagged With: Covidien, Medtronic, Medtronic buys Covidien, Newport Medical Instruments, U.S. Biomedical Advanced Research and Development Authority (BARDA), U.S. Department of Justice

What are the top COVID-19 vaccine candidates?

September 25, 2020 By Nancy Crotti

As of yesterday, five COVID-19 vaccine candidates had begun Phase 3 clinical trials as they seek to determine the safety and efficacy of their formulas. Researchers worldwide are testing 132 COVID-19 vaccine candidates, including 42 that are in clinical trials on humans and at least 92 in preclinical or animal trials, according to the New […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, BioNTech, coronavirus, COVID-19, GlaxoSmithKline plc, Johnson & Johnson, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Pfizer, Sanofi, U.S. Biomedical Advanced Research and Development Authority (BARDA)

J&J launches fourth large-scale COVID-19 vaccine trial

September 23, 2020 By Sean Whooley

Johnson & Johnson (NYSE:JNJ) has begun enrollment of adult volunteers for a fourth Phase 3 clinical trial of a COVID-19 vaccine candidate. The National Institutes of Health announced today that J&J’s Janssen Pharmaceuticals COVID-19 vaccine candidate (JNJ-78436725) has begun the Phase 3 trial to evaluate if it can prevent symptomatic COVID-19 after a single dose regimen. Up […]

Filed Under: Clinical Trials, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Janssen Pharmaceuticals, Johnson and Johnson, National Institutes of Health (NIH), U.S. Biomedical Advanced Research and Development Authority (BARDA)

BARDA awards $12.9M to Ortho Clinical for coronavirus antigen test

September 22, 2020 By Sean Whooley

Ortho Clinical Diagnostics announced that it received a nearly $12.9 million award from BARDA to support the development of its COVID-19 antigen test. Raritan, N.J.-based Ortho Clinical Diagnostics and the Biomedical Advanced Research and Development Authority (BARDA) are working together under a new contract as part of the government’s ongoing COVID-19 medical countermeasure development efforts, according […]

Filed Under: Business/Financial News, Diagnostics, Funding Roundup, Genomics/Molecular Diagnostics, Research & Development Tagged With: coronavirus, COVID-19, Ortho Clinical Diagnostics, U.S. Biomedical Advanced Research and Development Authority (BARDA)

These researchers adapted a stroke patient device for COVID-19

September 2, 2020 By Nancy Crotti

Designed to detect speech and swallowing problems, the device has found a new use in tracking cough frequency to alert healthcare providers that frontline workers may need to be tested for SARS-COV-2. Researchers in Chicago have adapted a flexible patch they developed to monitor stroke patients for swallowing trouble to help detect symptoms of COVID-19. […]

Filed Under: Featured, Research & Development, Respiratory Tagged With: coronavirus, COVID-19, FDA, Northwestern University, Shirley Ryan AbilityLab, Sonica Health, U.S. Biomedical Advanced Research and Development Authority (BARDA)

Merck, IAVI work to develop COVID-19 vaccine

May 26, 2020 By Sean Whooley

Merck (NYSE:MRK) and IAVI announced today that they are collaborating to develop an investigational vaccine against SARS-CoV-2 for preventing COVID-19. The vaccine candidate is slated to use the recombinant vesicular stomatitis virus (rVSV) technology used as the basis for Merck’s Ervebo Ebola Zaire virus vaccine, which was the first such vaccine to be approved for use in humans, […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: coronavirus, COVID-19, IAVI, Merck, U.S. Biomedical Advanced Research and Development Authority (BARDA)

Phlow lands $354m government contract for COVID-19 medications

May 19, 2020 By Sean Whooley

Phlow announced today that it received $354 million in U.S. government funding to manufacture essential medicines at risk of shortage, including those involved in the COVID-19 pandemic response. Richmond, Va.-based Phlow’s manufacturing is being funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the office of Assistant Secretary for Preparedness and Response (ASPR) […]

Filed Under: Business/Financial News, Contract Manufacturing, Funding Roundup, Pharmaceutical Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Phlow, U.S. Biomedical Advanced Research and Development Authority (BARDA)

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS